Meredith Brown-Tuttle

Vice President of Regulatory Affairs

Prior to participating in shaping the future drug development at Recursion, Meredith founded and ran a successful regulatory consulting firm, Regulatorium, working with small/medium drug, biologic and combination companies to successfully navigate global regulatory submissions, writing, training, intelligence and strategy requirements.

For the 16 years prior to that she held senior regulatory positions at several San Francisco Bay Area biotech companies writing INDs and NDAs, providing key drug development strategic insights; additionally, she acquired clinical operations, data management, project management and medical writing skills during her 30+ years in drug and device development.

Meredith studied biological psychology as an undergraduate at San Jose State University. In her spare time, she enjoys roller skating with her daughter, her pack of wild Dalmatians and dealing with her need to compulsively write regulatory books and articles.